Peptidream Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Peptidream Inc with three other
companies in this sector in Japan:
Japan Tissue Engineering Company Limited
sales of 1.43 billion Japanese Yen [US$12.39 million]
of which 93%
was Regenerative Medicine Products Business),
Trans Genic Inc
(2.29 billion Japanese Yen [US$19.83 million]
of which 48%
was CRO Business), and
Medinet Co., Ltd.
(1.91 billion Japanese Yen [US$16.53 million]
During the year ended June of 2016, sales at
Peptidream Inc were ¥4.33 billion (US$37.48 million).
increase of 74.9%
versus 2015, when the company's sales were ¥2.47 billion.
This was the fourth straight year of sales growth at Peptidream Inc.